Abstract:Objective To detect the expression of CD 44V 6, VEGF and nm23-H1 genes and evaluate its clinical significances on ovarian cancerous tissue.Methods Monoclonal antibodies to CD 44V 6,VEGF,nm23-H1 and SABC immunohistochemistry method were used to detect the expression of CD 44V 6,VEGF and nm23-H1 on the tumor cell in 65 cases of human ovarian cancerous tissue,30 benign ovarian tumor and on the normal ovarian tissues.Results 1) The positive expression rates of both CD 44V 6 and VEGF in groups of ovarian cancers, of stages Ⅱ-Ⅳand of the patient’s survival below 5 years were respectively were higher than that in groups of benign tumors and normal ovarian controls,of stage Ⅰand of the patient’s survival above 5 years,P0.05.The expression rate of CD 44V 6 in metastatic lesions were higher than that in the primary tumor,but that of VEGF was not significant between them.2) The positive expression rate of nm23-H1 in groups of stage Ⅱ-Ⅳ,of the metastases and of the patient’s survival below 5 years were respectively lower than that in the groups of stage Ⅰ-Ⅱ,of primary lesions and of the patient’s survival above 5 years,P0.05.The expression rate of nm23-H1 gene in group of ovarian cancers was higher than that of benign tumor or normal controls too.3) No significant difference was abserved between groups of the patient’s age,of histological types of cancers,of pathological grades of the malignancy and sizes of residual focuses of cancer.Conclusions 1) The results in the experiment indicate that as the expression of CD 44 V6 and VEGF is higher in poor differentiated tmuor and when the diseases reach the lase stage,which is concordance with some documents in which CD 44V 6 is an agent promoting growth, infiltration and metastasis of tumor,and VEGF promote tumor’s vessel growth.2) The higher expression of nm23-H1 primary cancer than that on metastatic lesion in late stage also reflect the function of nm23-H1 as metastasis supressor gene. The result of higher expression of nm23-H1 in cancer group than that in benign tumors or normal controls may be considered as a host compensative phenomenon to suppress tumor.

Relations between the expression of VEGF and its receptor KDR and the progression of epithelial ovarian cancer

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

The Role of Vascular Endothelial Growth Factor Receptor (KDR) in Invasion and Metastasis of Gastric Cancer

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

VEGF, VEGFRs Expressions and Activated STATs in Ovarian Epithelial Carcinoma

The correlation of VEGF expression with MVD in renal pelvic carcinoma and its clinical significance

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

The Correlation Between Expression of Vascular Endothelial Growth Factor and Invasiveness and Metastasis of Gastric Carcinoma

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

Relationship of Vascular Endothelial Growth Factor A Expression in Lymphangiogenesis and Angiogenesis

[Expression of Mrna Isoforms of Vascular Endothelial Growth Factor in Ovarian Carcinoma]

The relationship between expression of VEGF in colorectal cancer and pathological factors

Expression of EGFR and KRAS in Patients with Epithelial Ovarian Cancer and Its Clinical Significance

Relationship Between Expression of Foxp3, TGF-β1, VEGF, CD3-ζ, and IL-10 in Ovarian Cancer Tissues and the Prognosis of the Disease

[Tumor-Infiltrating Dendritic Cells in Epithelial Ovarian Carcinoma and Correlation with the Expression of Vascular Endothelial Growth Factor].

Expression of Vascular Endothelial Growth Factor (VEGF) and Its Receptor KDR in Hepatocellular Carcinoma

Expression of VEGF Receptor KDR in Different Originated Carcinomas

Expression and Correlation of Vascular Endothelial Growth Factor and Estrogen Receptor in Endometrial Carcinomas

Relationship between VEGF-C expres-sion and lymph node metastasis and prognosis in large intestinal carcinoma

Expression of CD44V6,VEGF and nm23-H1 on Ovarian Cancerous Tissue and Its Clinical Significance